510(k) K781909

CALCITONIN 125 by Cambridge Nuclear Radiopharmaceutical — Product Code JKR

K781909 is an FDA 510(k) premarket notification submitted by Cambridge Nuclear Radiopharmaceutical for the device "CALCITONIN 125". The FDA issued a decision of Substantially Equivalent on January 10, 1979. The device falls under product code JKR (Radioimmunoassay, Calcitonin), a Class II device regulated under 21 CFR 862.1140.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 10, 1979
Date Received
November 14, 1978
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Radioimmunoassay, Calcitonin
Device Class
Class II
Regulation Number
862.1140
Review Panel
CH
Submission Type